Virtue Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,392
Closed -$287K 350
2026
Q1
$287K Buy
+1,392
New +$300K 0.04% 263
2024
Q2
Sell
-9,317
Closed -$986K 380
2024
Q1
$986K Buy
9,317
+613
+7% +$66.1K 0.18% 104
2023
Q4
$922K Sell
8,704
-1,349
-13% -$134K 0.19% 103
2023
Q3
$951K Hold
10,053
0.16% 117
2023
Q2
$951K Buy
10,053
+304
+3% +$25.7K 0.16% 117
2023
Q1
$784K Sell
9,749
-407
-4% -$30.7K 0.13% 137
2022
Q4
$781K Buy
+10,156
New +$772K 0.12% 120
2018
Q4
Sell
-15,360
Closed -$829K 113
2018
Q3
$829K Buy
15,360
+5,579
+57% +$286K 0.18% 143
2018
Q2
$478K Buy
9,781
+209
+2% +$11.9K 0.23% 134
2018
Q1
$596K Sell
9,572
-1,368
-13% -$93.8K 0.31% 102
2017
Q4
$670K Buy
+10,940
New +$676K 0.38% 65

Other funds holding CAH

Virtue Capital Management's CAH Position: Q2 2026 in Review

Virtue Capital Management sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 1,392 shares — an estimated $287K sold.

Virtue Capital Management first reported a position in CAH in Q4 2017 and held it in 11 quarters. The position peaked at $986K in Q1 2024. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Virtue Capital Management reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • Virtue Capital Management sold 1,392 Cardinal Health shares in Q2 2026, an estimated $287K.
  • Virtue Capital Management first reported a position in Cardinal Health in Q4 2017 and held it in 11 quarters.
  • Virtue Capital Management's Cardinal Health position peaked at $986K in Q1 2024.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Virtue Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.